Article
Paraoxonase-1 (PON1) status in pancreatic cancer: relation to clinical parameters.
Folia biologica - 1 Jan 2012
Vecka M, Jáchymová M, Vávrová L, Kodydková J, Macášek J, Urbánek M, Krechler T, Slabý A, Dušková J, Muravská A, Zák A
Abstract excerpt
Human paraoxonase 1 (PON1) has been shown to decrease the level of systemic oxidative stress, which is thought to contribute to cancer development. The aim of this study was to examine the interrelationships between PON1 status and some clinical characteristics in patients with pancreatic cancer (PC). A group of 73 consecutive patients with PC (stage II-IV) and 73 control subjects were examined. Laboratory...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
